-
Study finds RSV treatment Beyfortus prevents 5,800 hospitalisations in France
26 Apr 2024 12:10 GMT
French health authorities released two studies following their rollout of the new preventive antibody Beyfortus.
Roughly 5,800 hospitalisations from bronchiolitis were avoided in France thanks to the new preventive medicine nirsevimab, Public Health France …
-
Innorna's broad-spectrum SARS-CoV-2 mRNA vaccine receives Phase II clinical trial approval from the FDA
26 Apr 2024 06:22 GMT
… the respiratory syncytial virus (RSV) vaccine, IN006, in … Phase I clinical trial and the FDA's approval … to-end development of innovative treatments for internal development and external … has established partnerships with pharma and biotech companies, such …
-
Study Highlights Reduced Disease Severity When Vaccinated Against RSV
25 Apr 2024 21:57 GMT
… the cohort trial that all presented a positive test for RSV, COVID … ill individuals. Additionally, treatment with antiviral and immunomodulatory medications was not considered … ;www.pharmacytimes.com/view/fda-accepts-priority-review-application-for-rsv …
-
New tool helps identify babies at high-risk for RSV
25 Apr 2024 19:47 GMT
… 1 to receive a preventive medication before RSV season (October-April), according … the medication nirsevimab, commonly used as a preventive in newborns.
“We developed … palivizumab.
Nirsevimab is long-acting drug and only requires one dose …
-
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
25 Apr 2024 17:00 GMT
… Drugs Market Report Pulmonary Drugs Overview Pulmonary drugs encompass a diverse array of medications … alternative treatment methods, and potential drug side … Development, Arrowhead Pharmaceuticals, Hoffman-La-Roche, GlaxoSmithKline, Biohaven Pharmaceutical, …
-
mRNA-1345 for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2032 - ResearchAndMarkets.com
25 Apr 2024 12:05 GMT
… about other emerging therapies in RSV.
Drug Summary
The mRNA-1345 vaccine … of mRNA-1345 for RSV covering trial interventions, trial conditions, trial status, start and … companies are developing therapies that focus on novel approaches to treat…
-
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
25 Apr 2024 10:27 GMT
… Amolyt Pharma in March to beef up the flow of drugs it … course to look at business development,” he said in a conference … US, and the rare-disease drug Ultomiris, helped revenue rise … — including the timing of future treatments and their revenue potential — at …
-
Cost of developing new drugs may be far lower than industry claims, trial reveals
25 Apr 2024 10:16 GMT
… a four-drug combination treatment for drug-resistant tuberculosis … transparency in clinical trial costs is a … the International Federation of Pharmaceutical Manufacturers and Traders (IFPMA … have developed over 470 medicines to treat diseases such …
-
How We Treat The Homeless Is How We Treat God
24 Apr 2024 08:58 GMT
… those who promote such ill-treatment of the homeless say is … and needy” (Ezek. 16:49 RSV). It is a country which … , and how we treat them is how we treat God. So many … such knowledge” (Prov. 29:7 RSV). If we are concerned about …
-
Viral infection had 'no material role' in death of baby girl strapped face down to nursery bean bag, trial hears
23 Apr 2024 18:41 GMT
… was treated for symptoms of “RSV bronchiolitis”, described as a “ … of her manslaughter by ill treatment. READ MORE Tributes pour in … read on Tuesday at her trial at Manchester Crown Court, … hospital was above average for RSV bronchiolitis it was nothing …